Next Article in Journal
Liver Transplantation for Alcoholic Liver Disease and Hepatocellular Carcinoma
Next Article in Special Issue
Targeting the Hippo Pathway and Cancer through the TEAD Family of Transcription Factors
Previous Article in Journal
Integrin Inhibitors in Prostate Cancer
Open AccessEditor’s ChoiceReview

Linking Extracellular Matrix Agrin to the Hippo Pathway in Liver Cancer and Beyond

Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A-STAR), 61 Biopolis Drive, Proteos, Singapore 138673, Singapore
*
Author to whom correspondence should be addressed.
Cancers 2018, 10(2), 45; https://doi.org/10.3390/cancers10020045
Received: 4 January 2018 / Revised: 5 February 2018 / Accepted: 5 February 2018 / Published: 6 February 2018
In addition to the structural and scaffolding role, the extracellular matrix (ECM) is emerging as a hub for biomechanical signal transduction that is frequently relayed to intracellular sensors to regulate diverse cellular processes. At a macroscopic scale, matrix rigidity confers long-ranging effects contributing towards tissue fibrosis and cancer. The transcriptional co-activators YAP/TAZ, better known as the converging effectors of the Hippo pathway, are widely recognized for their new role as nuclear mechanosensors during organ homeostasis and cancer. Still, how YAP/TAZ senses these “stiffness cues” from the ECM remains enigmatic. Here, we highlight the recent perspectives on the role of agrin in mechanosignaling from the ECM via antagonizing the Hippo pathway to activate YAP/TAZ in the contexts of cancer, neuromuscular junctions, and cardiac regeneration. View Full-Text
Keywords: Hippo pathway; agrin; YAP/TAZ; mechanotransduction; liver cancer; extracellular matrix; cardiac regeneration; neuromuscular junctions Hippo pathway; agrin; YAP/TAZ; mechanotransduction; liver cancer; extracellular matrix; cardiac regeneration; neuromuscular junctions
Show Figures

Figure 1

MDPI and ACS Style

Chakraborty, S.; Hong, W. Linking Extracellular Matrix Agrin to the Hippo Pathway in Liver Cancer and Beyond. Cancers 2018, 10, 45. https://doi.org/10.3390/cancers10020045

AMA Style

Chakraborty S, Hong W. Linking Extracellular Matrix Agrin to the Hippo Pathway in Liver Cancer and Beyond. Cancers. 2018; 10(2):45. https://doi.org/10.3390/cancers10020045

Chicago/Turabian Style

Chakraborty, Sayan; Hong, Wanjin. 2018. "Linking Extracellular Matrix Agrin to the Hippo Pathway in Liver Cancer and Beyond" Cancers 10, no. 2: 45. https://doi.org/10.3390/cancers10020045

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop